[Potentialities of treating secondary dysthymia with painful dysfunction of temporomandibular joint].
The quality of life and presence of depressions were evaluated in patients with painful temporomandibular dysfunction and the advantages of serotonin antidepressants in combined therapy of this condition were discussed. The findings indicate a decrease of the quality of life and hypothymic reactions in this category of patients. Addition of serotonin antidepressants to combined therapy appreciably improved the quality of life and more rapidly led to reduction of depressive symptoms.
Gorozhankina
E A
EA
Markov
B P
BP
Mamedov
F M
FM
D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D019263:Dysthymic Disorder / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D010146:Pain / Q000150:complications; D011788:Quality of Life; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use*; D013706:Temporomandibular Joint Dysfunction Syndrome / Q000150:complications / Q000523:psychology*; D016896:Treatment Outcome
D018687:Antidepressive Agents, Second-Generation; D017367:Selective Serotonin Reuptake Inhibitors